QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, November 5, 2008, 28(45):11537-11549; doi:10.1523/JNEUROSCI.1490-08.2008

This Article Full Text Full Text (PDF) Supplemental Data Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Traka, M. Articles by Popko, B. Search for Related Content PubMed PubMed Citation Articles by Traka, M. Articles by Popko, B.

 Previous Article  |  Next Article 

Neurobiology of Disease
Nur7 Is a Nonsense Mutation in the Mouse Aspartoacylase Gene That Causes Spongy Degeneration of the CNS

Maria Traka,¹ Robert L. Wollmann,² Sonia R. Cerda,³ Jason Dugas,⁴ Ben A. Barres,⁴ and Brian Popko¹

¹Jack Miller Center for Peripheral Neuropathy, Department of Neurology, and Departments of ²Pathology and ³Medicine, Division of Gastroenterology, The University of Chicago, Chicago, Illinois 60637, and ⁴Department of Neurobiology, Stanford University School of Medicine, Stanford, California 94305-5125

Correspondence should be addressed to Brian Popko, Jack Miller Center for Peripheral Neuropathy, Department of Neurology, MC 2030, The University of Chicago, Chicago, IL 60637. Email: bpopko{at}uchicago.edu

Aspartoacylase (ASPA) is an oligodendrocyte-restricted enzyme that catalyzes the hydrolysis of neuronally derived N-acetylaspartate (NAA) to acetate and aspartic acid. ASPA deficiency leads to the fatal childhood autosomal recessive leukodystrophy Canavan disease (CD). Here we demonstrate that the previously described ENU-induced nur7 mouse mutant is caused by a nonsense mutation, Q193X, in the Aspa gene (Aspa^nur7). Homozygous Aspa^nur7nur7 mice do not express detectable Aspa protein and display an early-onset spongy degeneration of CNS myelin with increased NAA levels similar to that observed in CD patients. In addition, CNS regions rich in neuronal cell bodies also display vacuolization. Interestingly, distinct myelin rich areas, such as the corpus callosum, optic nerve, and spinal cord white matter appear normal in Aspa^nur7/nur7 mice. Reduced cerebroside synthesis has been demonstrated in CD patients and animal models. To determine the potential relevance of this observation in disease pathogenesis, we generated Aspa^nur7/nur7 mice that were heterozygous for a null allele of the gene that encodes the enzyme UDP-galactose:ceramide galactosyltransferase (Cgt), which is responsible for catalyzing the synthesis of the abundant myelin galactolipids. Despite reduced amounts of cerebrosides, the Aspa^nur7/nur7;Cgt^+/– mice were not more severely affected than the Aspa^nur7 mutants, suggesting that diminished cerebroside synthesis is not a major contributing factor in disease pathogenesis. Furthermore, we found that myelin degeneration leads to significant axonal loss in the cerebellum of older Aspa^nur7 mutants. This finding suggests that axonal pathology caused by CNS myelin defects may underlie the neurological disabilities that CD patients develop at late stages of the disease.

Key words: ASPA; Canavan disease; N-acetylaspartate (NAA); spongy degeneration; vacuolation; leukodystrophy

---

Received April 7, 2008; revised Sept. 19, 2008; accepted Sept. 22, 2008.

Correspondence should be addressed to Brian Popko, Jack Miller Center for Peripheral Neuropathy, Department of Neurology, MC 2030, The University of Chicago, Chicago, IL 60637. Email: bpopko{at}uchicago.edu

This article has been cited by other articles:

				D. S. Douglas, J. L. Moran, J. R. Bermingham Jr, X.-J. Chen, D. N. Brindley, B. Soliven, D. R. Beier, and B. Popko Concurrent Lpin1 and Nrcam Mouse Mutations Result in Severe Peripheral Neuropathy with Transitory Hindlimb Paralysis J. Neurosci., September 30, 2009; 29(39): 12089 - 12100. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help